Tech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhinomed.
RELATED STOCKHEAD STORIES
News
Lunchtime ASX small cap wrap: Who’s shocking everyone today?
Health & Biotech
Health: Immutep bounces off decade-long lows thanks to cash from GSK
News
Rise & Shine: What you need to know before the ASX opens
News
Weed Week: American pot could be worth $60 billion by 2025
News
Weekly small cap wrap: Who deserves a high five?
News
Weed Week: US looks at ways to help cannabis players get banking access
Health & Biotech
Rhinomed will explore links between poor sleep and suicide in new study
Health & Biotech
Health: Neuren’s secondary drug shows more efficacy in mice, shares rise 50pc
Health & Biotech
Rhinomed breathing easy thanks to strong March quarter, shares rise 26pc
News
Quarterlies: Marley Spoon is spending now to profit later, aims to break even by 2020
Health & Biotech
Kim Kardashian is having a CBD baby shower. Has cannabis peaked?
Health & Biotech
Two medical device smallcaps are up, one is down after a soft quarterly
Health & Biotech
Weed week: wtf happened with MMJ?
Health & Biotech
Weed week: here’s all the news driving ASX cannabis stocks
Health & Biotech
Weed week: it’s reefer madness as global pot stocks pass $6b in fund raising
Health & Biotech
These seven ASX-listed pot stocks are hoping for a US high
Health & Biotech
